Squarepoint Ops LLC Bolt Biotherapeutics, Inc. Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.01 - $1.4 $1,769 - $2,452	-1,752 Reduced 2.2%	78,020 $109,000
Q4 2023 Feb 14, 2024	BUY	$0.85 - $1.12 $13,395 - $17,650	15,759 Added 24.62%	79,772 $89,000
Q2 2023 Aug 14, 2023	BUY	$1.27 - $1.95 $81,296 - $124,825	64,013 New	64,013 $81,000
Q1 2022 May 16, 2022	SELL	$2.74 - $4.82 $38,738 - $68,145	-14,138 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.19 - $13.97 $59,238 - $197,507	14,138 New	14,138 $69,000

19.1M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $18.8M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.